1 Fleming TR, DeMets DL, Roe MT, et al. Data monitoring committees: promoting best practices to address emerging challenges. Clin Trials 2017; 14:115–23.doi:10.1177/1740774516688915
2 Califf R, Zarin D, Kramer J. et al. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA, 2012; 307 (17): 1838-1847.
3 Use of data monitoring committees in clinical trials. Guidance for industry. February 2024.